![Rob R. Ruijtenbeek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rob R. Ruijtenbeek
Corporate Officer/Principal en PamGene International BV .
Cargos activos de Rob R. Ruijtenbeek
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PamGene International BV
![]() PamGene International BV Pharmaceuticals: MajorHealth Technology PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing. | Corporate Officer/Principal | 01/01/2001 | - |
Historial de carrera de Rob R. Ruijtenbeek
Antiguos cargos conocidos de Rob R. Ruijtenbeek.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
University of Leiden | Corporate Officer/Principal | - | - |
PamGene BV
![]() PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Director Técnico/Científico/I+D | 01/01/2001 | - |
Formación de Rob R. Ruijtenbeek.
University of Utrecht | Doctorate Degree |
Estadísticas
Internacional
Países Bajos | 5 |
Operativa
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
PamGene BV
![]() PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Health Technology |
PamGene International BV
![]() PamGene International BV Pharmaceuticals: MajorHealth Technology PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing. | Health Technology |
- Bolsa de valores
- Insiders
- Rob R. Ruijtenbeek
- Experiencia